Immunotech Biopharm Ltd (6978.HK)
HKD 4.09
(0.49%)
HKD 4.09
(0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 230.54 Million | 268.83 Million | 335.59 Million | 383.22 Million | 110.86 Million | 42.43 Million |
| Selling, General and Administrative Expenses | 53.22 Million | 97.7 Million | 104.25 Million | 106.2 Million | 36.82 Million | 11.64 Million |
| Research and Development Expenses | 177.32 Million | 69.76 Million | 93.6 Million | 278.62 Million | 61.97 Million | 31.17 Million |
| Other Expenses | - | 101.36 Million | 137.73 Million | -1.6 Million | 12.05 Million | 69 Thousand |
| Cost and Expenses | 230.54 Million | 268.83 Million | 335.59 Million | 383.22 Million | 110.86 Million | 42.43 Million |
| Operating Income | -230.54 Million | -280.23 Million | -333.35 Million | -419.83 Million | -110.14 Million | -42.43 Million |
| Interest Expense | - | 6.13 Million | 3.67 Million | 2.38 Million | 2.07 Million | 1.13 Million |
| Income Tax Expense | - | 31.73 Million | 20.87 Million | 19.21 Million | -1.34 Million | 8.67 Million |
| Earnings before Tax | -335.47 Million | -321.09 Million | -354.61 Million | -439.12 Million | -109.05 Million | -34.88 Million |
| Net Income | -334.81 Million | -352.83 Million | -375.48 Million | -458.34 Million | -107.71 Million | -34.76 Million |
| Earnings Per Share Basic | -0.65 | -0.69 | -0.73 | -1.03 | -0.22 | -0.07 |
| Earnings Per Share Diluted | -0.65 | -0.69 | -0.73 | -1.03 | -0.22 | -0.07 |
| Weighted Average Shares Outstanding | 514.58 Million | 514.58 Million | 514.58 Million | 443.81 Million | 500 Million | 500 Million |
| Weighted Average Shares Outstanding (Diluted) | 514.58 Million | 514.58 Million | 514.58 Million | 443.81 Million | 500 Million | 500 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -178.83 Million | -236.16 Million | -324.33 Million | -333.98 Million | -86.78 Million | -42.32 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | 28.15 Million |
| Gross Profit | - | - | - | - | - | -28.15 Million |
| Operating Expenses | 57.08 Thousand | 57.08 Thousand | 329.96 Million | 65.59 Thousand | 106.67 Thousand | 58.31 Thousand |
| Selling, General and Administrative Expenses | 11.52 Thousand | 11.52 Thousand | - | 14.09 Thousand | 14.09 Thousand | 12.51 Thousand |
| Research and Development Expenses | 45.55 Thousand | 45.55 Thousand | - | 51.5 Thousand | 51.5 Thousand | 37.15 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 57.08 Thousand | 57.08 Thousand | 329.96 Million | 65.59 Thousand | 106.67 Thousand | 58.31 Thousand |
| Operating Income | -57.08 Thousand | -57.08 Thousand | -231.04 Million | -65.59 Thousand | -65.77 Thousand | -49.74 Thousand |
| Interest Expense | - | - | - | - | - | 4.94 Million |
| Income Tax Expense | -471.00 | -471.00 | -660.00 | -85.50 | -86.00 | -551.9 Thousand |
| Earnings before Tax | -46.27 Thousand | -46.27 Thousand | -335.47 Million | -108.43 Thousand | -108.43 Thousand | -59.3 Thousand |
| Net Income | -46.25 Thousand | -46.25 Thousand | -334.81 Million | -108.35 Thousand | -108.35 Thousand | -59.05 Thousand |
| Earnings Per Share Basic | -0.00 | -0.09 | - | -0.21 | -0.21 | -0.12 |
| Earnings Per Share Diluted | -0.00 | -0.09 | - | -0.21 | -0.21 | -0.11 |
| Weighted Average Shares Outstanding | 513.97 Million | 513.97 Million | 514.58 Million | 514.58 Million | 514.58 Million | 513.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 514.58 Million | 514.58 Million | 514.58 Million | 514.58 Million | 514.58 Million | 514.58 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -42.34 Thousand | -42.34 Thousand | - | -52.75 Thousand | -52.75 Thousand | -36.66 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CDNIF
108675
4972
FMCC
000543
KSC